Our team includes healthcare executives, venture capitalists, physician inventors and practitioners as well as FDA experts. BioStar Capital’s select team of Medical Venture Partners (MVPs) collaborates with the leadership team to evaluate clinical significance, intellectual property, likelihood of market acceptance, competition, re-imbursement models, and the likelihood of exit prior to any investment.